One-pot, high-yielding synthesis of novel dihydrothiazolo[3,2-a] pyrimidinones

Synthetic Communications

Volumn 36, Issue 4, 2006, Pages 495-500

  Rotili, Dante ^a   Mai, Antonello ^a   Ambrogio, Ilaria ^a   Fabrizi, Giancarlo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

2 thiouracils; Dihydrothiazolo 3,2 a pyrimidinone; Ethyl 4 bromocrotonate; Regioselective

Indexed keywords

CROTONIC ACID DERIVATIVE; PYRIMIDINONE DERIVATIVE; THIOURACIL DERIVATIVE;

ARTICLE; CHEMICAL REACTION; DRUG SYNTHESIS; ROOM TEMPERATURE; STEREOCHEMISTRY; SUBSTITUTION REACTION;

EID: 31744445689     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910500384996     Document Type: Article

References (12)

1. Tanaka, H.; Ubasawa, M.; Sekiya, K.; Nitta, I.; Baba, M.; Shigeta, S.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogs: Effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity. J. Med. Chem. 1992, 35, 337-345.
2. Artico, M. Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): The DABO family. Drugs Fut. 2002, 27 (159-175), references cited therein.
3. Mai, A.; Artico, M.; Ragno, R.; Sbardella, G.; Massa, S.; Musiu, C.; Mura, M.; Marturana, F.; Cadeddu, A.; Maga, G.; La Colla, P. 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H) -ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family. Bioorg. Med. Chem. 2005, 13, 2065-2077.
4. Kundu, N. G.; Das, P.; Balzarini, J.; De Clercq, E. Palladium-catalyzed synthesis of [E]-6-(2-acylvinyl)uracils and [E]-6-(2-acylvinyl)-1-[(2- hydroxyethoxy)-methyl]uracils - their antiviral and cytotoxic activities. Bioorg. Med. Chem. 1997, 5, 2011-2018.
5. Felczak, K.; Drabikowska, A.; Vilpo, J. A.; Kulikowski, T.; Shugar, D. 6-Substituted and 5,6-disubstituted derivatives of uridine: Stereoselective synthesis, interaction with uridine phosphorylase, and in vitro antitumor activity. J. Med. Chem. 1996, 39, 1720-1728.
6. Zorbach, W. W.; Tipson, R. S. Synthetic Procedure in Nucleic Acid Chemistry; Interscience: London, 1968, pp. 53-115.
7. Botta, M.; Saladino, R.; Occhionero, F.; Nicoletti, R. Trends Org. Chem. 1995, 5, 57-81.
8. Mai, A.; Massa, S.; Rotili, D.; Cerbara, I.; Valente, S.; Pezzi, R.; Simeoni, S.; Ragno, R. Histone deacetylation in epigenetics: An attractive target for anticancer therapy. Med. Res. Rev. 2005, 25, 261-309.
9. Mai, A.; Massa, S.; Ragno, R.; Cerbara, I.; Jesacher, F.; Loidl, P.; Brosch, G. 3-(4-Aroyl-1 -methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures. J. Med. Chem. 2003, 46, 512-524.
10. Mai, A.; Massa, S.; Cerbara, I.; Valente, S.; Ragno, R.; Bottoni, P.; Scatena, R.; Loidl, P.; Brosch, G. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy- 2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole C2 and/or C4 substitutions on biological activity. J. Med. Chem. 2004, 47, 1098-1109.
11. Mai, A.; Massa, S.; Pezzi, R.; Simeoni, S.; Rotili, D.; Nebbioso, A.; Scognamiglio, A.; Altucci, A.; Loidl, P.; Brosch, G. Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxamides. J. Med. Chem. 2005, 48, 3344-3353.
12. Rotili, D.; Pezzi, R.; Loidl, P.; Brosch, G.; Massa, S.; Mai, A. Design, synthesis, and biological evaluation of uracil-based hydroxy-amides (UBHAs) as a new class of HDAC inhibitors. Drugs Fut. 2004, 29 (Suppl.A), 64.